Employee stock options add 3,675 Dr. Reddy’s (NYSE: RDY) shares

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited has allotted 3,675 equity shares of Re.1 each on March 26, 2026 to eligible employees who exercised stock options under the Dr. Reddy’s Employees ADR Stock Option Scheme, 2007. These equity shares rank pari passu with the company’s existing shares, and total issued shares after this allotment are stated as 83,46,57,970, with a corresponding issued share capital of Rs. 83,46,57,970.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

March, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                               Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                                     No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated March 26, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: March 26, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:     + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

March 26, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs

This is to inform you that the Company has allotted 3,675 equity shares of Re.1/- each of the Company, fully paid up, on March 26, 2026, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:     + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

1	Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad – 500034
2	Name of the Stock Exchanges on which the company’s shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3	Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4	Filing Number, if any: NA
5	Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy’s Employees ADR Stock Option Scheme, 2007.
6	Kind of security to be listed: Equity Shares
7	Par value of the shares: Re. 1/-
8	Date of issue of shares: March 26, 2026 (Date of allotment on exercise)
9	Number of shares issued: 3,675 equity shares
10	Share Certificate No., if applicable: NA
11	Distinctive number of the share, if applicable: 834653296 to 834656970
12	ISIN Number of the shares if issued in Demat: INE089A01031
13	Exercise price per share: (i)    575 shares at Re.1/- each (ii)   3,100 shares at Rs. 735.80/- each
14	Premium per share: (i)    575 shares at Nil premium (ii)   3,100 shares at Rs.734.80/- each
15	Total Issued shares after this issue: 83,46,57,970 (*)
16	Total Issued share capital after this issue: Rs. 83,46,57,970 /-
17	Details of any lock-in on the shares: NA
18	Date of expiry of lock-in:  NA
19	Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20	Details of listing fees, if payable: NA

(*) Total paid up capital after this issue: 83,46,56,970 equity shares of Re.1 each, aggregating to Rs. 83,46,56,970/- (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of non-payment of allotment money.)

FAQ

What did Dr. Reddy’s Laboratories (RDY) announce in this Form 6-K?

Dr. Reddy’s announced the allotment of 3,675 equity shares of Re.1 each to employees on March 26, 2026. The shares were issued upon exercise of stock options under the Dr. Reddy’s Employees ADR Stock Option Scheme, 2007.

How many new Dr. Reddy’s (RDY) shares were issued under employee stock options?

The company issued 3,675 new equity shares of Re.1 each to employees. These arose from stock options exercised under the Dr. Reddy’s Employees ADR Stock Option Scheme, 2007, and are fully paid up like the existing equity shares.

What exercise prices applied to the Dr. Reddy’s (RDY) employee stock options?

Two exercise prices applied: 575 shares were exercised at Re.1 per share, and 3,100 shares at Rs. 735.80 per share. The latter embeds a premium of Rs. 734.80 per share over the Re.1 face value.

How did the Dr. Reddy’s (RDY) share capital change after this allotment?

After this allotment, total issued shares are stated as 83,46,57,970, with total issued share capital of Rs. 83,46,57,970. A note explains a 1,000-share difference due to forfeited shares in 1988 for non-payment of allotment money.

Are the newly issued Dr. Reddy’s (RDY) shares identical to existing shares?

Yes, the company states the new 3,675 equity shares rank pari passu with existing equity shares. This means they have the same rights as current shares, including voting rights and entitlement to dividends, from the date of allotment.

On which exchanges are Dr. Reddy’s (RDY) shares and ADRs listed?

Equity shares are listed on BSE Limited and the National Stock Exchange of India Limited. American Depositary Receipts are listed on the New York Stock Exchange and NSE IFSC Limited, allowing international investors to trade Dr. Reddy’s securities.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 65.9 KB